DE60129863D1 - Hydroxysubstituierte 2-Azetidinone verwendbar als Hypocholesterolemische Arzneimittel - Google Patents

Hydroxysubstituierte 2-Azetidinone verwendbar als Hypocholesterolemische Arzneimittel

Info

Publication number: DE60129863D1
Authority: DE; Germany
Prior art keywords: hydroxy; substituted; azetidinones useful; hypocholesterolemic drugs; hypocholesterolemic
Prior art date: 2000-12-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60129863T

Other languages

English (en)

Other versions

DE60129863T2 (de

Inventor

Anima Ghosal

Shmuel Zbaida

Swapan K Chowdhury

Robert M Iannucci

Wenqing Feng

Kevin B Alton

James E Patrick

Harry R Davis

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck Sharp and Dohme LLC

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-20

Filing date

2001-12-17

Publication date

2007-09-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22973953&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60129863(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-12-17 Application filed by Schering Corp filed Critical Schering Corp

2007-09-20 Application granted granted Critical

2007-09-20 Publication of DE60129863D1 publication Critical patent/DE60129863D1/de

2008-04-30 Publication of DE60129863T2 publication Critical patent/DE60129863T2/de

2021-12-18 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Saccharide Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DE60129863T 2000-12-20 2001-12-17 Hydroxysubstituierte 2-Azetidinone verwendbar als Hypocholesterolemische Arzneimittel Expired - Lifetime DE60129863T2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US25687500P	2000-12-20	2000-12-20
US256875P		2000-12-20

Publications (2)

Publication Number	Publication Date
DE60129863D1 true DE60129863D1 (de)	2007-09-20
DE60129863T2 DE60129863T2 (de)	2008-04-30

Family

ID=22973953

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE60106489T Expired - Lifetime DE60106489T2 (de)	2000-12-20	2001-12-17	Zuckersubstituierte 2-azetidinone verwendbar als hypocholesterdenische arzneimittel
DE60129863T Expired - Lifetime DE60129863T2 (de)	2000-12-20	2001-12-17	Hydroxysubstituierte 2-Azetidinone verwendbar als Hypocholesterolemische Arzneimittel

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DE60106489T Expired - Lifetime DE60106489T2 (de)	2000-12-20	2001-12-17	Zuckersubstituierte 2-azetidinone verwendbar als hypocholesterdenische arzneimittel

Country Status (34)

Country	Link
US (1)	US20020137690A1 (de)
EP (1)	EP1347987B1 (de)
JP (2)	JP4351842B2 (de)
KR (1)	KR100883461B1 (de)
CN (1)	CN100475829C (de)
AR (1)	AR035611A1 (de)
AT (2)	ATE369334T1 (de)
AU (2)	AU2002231049B2 (de)
BR (1)	BR0116212A (de)
CA (1)	CA2432798C (de)
CY (1)	CY1106912T1 (de)
CZ (1)	CZ302193B6 (de)
DE (2)	DE60106489T2 (de)
DK (2)	DK1593670T3 (de)
EC (1)	ECSP034659A (de)
ES (2)	ES2287826T3 (de)
GE (1)	GEP20053548B (de)
HU (1)	HUP0302269A3 (de)
IL (1)	IL155771A0 (de)
MA (1)	MA26975A1 (de)
MX (1)	MXPA03005671A (de)
MY (1)	MY129148A (de)
NO (2)	NO326981B1 (de)
NZ (1)	NZ525722A (de)
PE (1)	PE20020718A1 (de)
PL (1)	PL208242B1 (de)
PT (2)	PT1347987E (de)
RU (1)	RU2297422C2 (de)
SI (2)	SI1593670T1 (de)
SK (1)	SK286703B6 (de)
TR (1)	TR200402758T4 (de)
TW (1)	TWI316942B (de)
WO (1)	WO2002050090A1 (de)
ZA (1)	ZA200303694B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6982251B2 (en)	2000-12-20	2006-01-03	Schering Corporation	Substituted 2-azetidinones useful as hypocholesterolemic agents
DK1355644T3 (da)	2001-01-26	2006-10-23	Schering Corp	Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
US7071181B2 (en)	2001-01-26	2006-07-04	Schering Corporation	Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
CZ301871B6 (cs)	2001-01-26	2010-07-14	Schering Corporation	Kombinace aktivátoru receptoru, aktivovaného proliferátorem peroxisomu fenofibrátu s inhibitorem vstrebávání sterolu ezetimibem pro použití pri cévních chorobách
ATE305459T1 (de)	2001-03-28	2005-10-15	Schering Corp	Verfahren für die enantioselektive synthese von azetidinon-zwischenprodukten
US7053080B2 (en)	2001-09-21	2006-05-30	Schering Corporation	Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en)	2001-09-21	2006-06-06	Schering Corporation	Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7132415B2 (en)	2001-09-21	2006-11-07	Schering Corporation	Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
GB0215579D0 (en)	2002-07-05	2002-08-14	Astrazeneca Ab	Chemical compounds
AR040588A1 (es) *	2002-07-26	2005-04-13	Schering Corp	Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
US20040092499A1 (en)	2002-11-06	2004-05-13	Schering Corporation	Methods and therapeutic combinations for the treatment of autoimmune disorders
US7459442B2 (en)	2003-03-07	2008-12-02	Schering Corporation	Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
MXPA05009502A (es)	2003-03-07	2005-10-18	Schering Corp	Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
EP1601669B1 (de)	2003-03-07	2008-12-24	Schering Corporation	Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
CN100439361C (zh)	2003-03-07	2008-12-03	先灵公司	取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
JP2005015434A (ja)	2003-06-27	2005-01-20	Kotobuki Seiyaku Kk	血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
EP1522541A1 (de) *	2003-10-07	2005-04-13	Lipideon Biotechnology AG	Neue hypocholesterolemische Verbindungen
EP1918000A2 (de)	2003-11-05	2008-05-07	Schering Corporation	Verbindungen aus lipidverändernden Wirkstoffen und substituierten Azetidinonen und Behandlungen für Gefäßzustände
WO2005061452A1 (en)	2003-12-23	2005-07-07	Astrazeneca Ab	Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
EP1699760B1 (de)	2003-12-23	2017-05-17	Merck Sharp & Dohme Corp.	Antihypercholesterinämische verbindungen
GB0329778D0 (en) *	2003-12-23	2004-01-28	Astrazeneca Ab	Chemical compounds
WO2006039334A1 (en) *	2004-09-29	2006-04-13	Schering Corporation	Combinations of substituted azetidonones and cb1 antagonists
US7737155B2 (en)	2005-05-17	2010-06-15	Schering Corporation	Nitrogen-containing heterocyclic compounds and methods of use thereof
AR054482A1 (es) *	2005-06-22	2007-06-27	Astrazeneca Ab	Derivados de azetidinona para el tratamiento de hiperlipidemias
SA06270191B1 (ar)	2005-06-22	2010-03-29	استرازينيكا ايه بي	مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
KR20080096851A (ko) *	2006-03-06	2008-11-03	테바 파마슈티컬 인더스트리즈 리미티드	에제티미베 조성물
AR060623A1 (es)	2006-04-27	2008-07-02	Astrazeneca Ab	Compuestos derivados de 2-azetidinona y un metodo de preparacion
CA2682202C (en) *	2007-04-02	2016-01-12	Theracos, Inc.	Benzylic glycoside derivatives and methods of use
US20110245209A1 (en)	2008-12-16	2011-10-06	Schering Corporation	Pyridopyrimidine derivatives and methods of use thereof
WO2010075069A1 (en)	2008-12-16	2010-07-01	Schering Corporation	Bicyclic pyranone derivatives as nicotinic acid receptor agonists
WO2010093752A1 (en) *	2009-02-11	2010-08-19	Dow Agrosciences Llc	Pesticidal compositions
EP2403848A1 (de)	2009-03-06	2012-01-11	Lipideon Biotechnology AG	Pharmazeutische hypocholesterinemische zusammensetzungen
WO2010113175A2 (en)	2009-04-01	2010-10-07	Matrix Laboratories Ltd	Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
CN101993403B (zh)	2009-08-11	2012-07-11	浙江海正药业股份有限公司	氮杂环丁酮类化合物及医药应用
KR101102749B1 (ko) *	2009-11-30	2012-01-05	최길용	곱셈 학습기
KR20150079373A (ko)	2013-12-30	2015-07-08	한미약품 주식회사	에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제
CN105055404B (zh) *	2015-08-19	2017-07-18	四川大学	Hmgcs2抑制剂在制备治疗可卡因成瘾的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
LT3595B (en) *	1993-01-21	1995-12-27	Schering Corp	Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
US5631365A (en) *	1993-09-21	1997-05-20	Schering Corporation	Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5627176A (en) *	1994-03-25	1997-05-06	Schering Corporation	Substituted azetidinone compounds useful as hypocholesterolemic agents
US5633246A (en) *	1994-11-18	1997-05-27	Schering Corporation	Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
EP0877750B1 (de) *	1995-10-31	2002-06-19	Schering Corporation	Zuckersubstituierte 2-azetidinone, verwendbar als hypocholesterdenische arzneimittel
US5756470A (en) *	1996-10-29	1998-05-26	Schering Corporation	Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
AUPQ342599A0 (en) *	1999-10-14	1999-11-04	University Of Melbourne, The	Conjugates and uses thereof

2001
- 2001-12-17 PL PL363237A patent/PL208242B1/pl not_active IP Right Cessation
- 2001-12-17 PT PT01991315T patent/PT1347987E/pt unknown
- 2001-12-17 AU AU2002231049A patent/AU2002231049B2/en not_active Ceased
- 2001-12-17 CN CNB01821133XA patent/CN100475829C/zh not_active Expired - Fee Related
- 2001-12-17 AU AU3104902A patent/AU3104902A/xx active Pending
- 2001-12-17 DK DK05004699T patent/DK1593670T3/da active
- 2001-12-17 CZ CZ20031674A patent/CZ302193B6/cs not_active IP Right Cessation
- 2001-12-17 AR ARP010105837A patent/AR035611A1/es not_active Application Discontinuation
- 2001-12-17 AT AT05004699T patent/ATE369334T1/de active
- 2001-12-17 AT AT01991315T patent/ATE279425T1/de active
- 2001-12-17 JP JP2002551983A patent/JP4351842B2/ja not_active Expired - Fee Related
- 2001-12-17 HU HU0302269A patent/HUP0302269A3/hu unknown
- 2001-12-17 DE DE60106489T patent/DE60106489T2/de not_active Expired - Lifetime
- 2001-12-17 RU RU2003122520/04A patent/RU2297422C2/ru not_active IP Right Cessation
- 2001-12-17 IL IL15577101A patent/IL155771A0/xx not_active IP Right Cessation
- 2001-12-17 SI SI200130760T patent/SI1593670T1/sl unknown
- 2001-12-17 US US10/023,295 patent/US20020137690A1/en not_active Abandoned
- 2001-12-17 DE DE60129863T patent/DE60129863T2/de not_active Expired - Lifetime
- 2001-12-17 EP EP01991315A patent/EP1347987B1/de not_active Expired - Lifetime
- 2001-12-17 WO PCT/US2001/049127 patent/WO2002050090A1/en active Application Filing
- 2001-12-17 NZ NZ525722A patent/NZ525722A/en not_active IP Right Cessation
- 2001-12-17 ES ES05004699T patent/ES2287826T3/es not_active Expired - Lifetime
- 2001-12-17 PT PT05004699T patent/PT1593670E/pt unknown
- 2001-12-17 MX MXPA03005671A patent/MXPA03005671A/es active IP Right Grant
- 2001-12-17 PE PE2001001260A patent/PE20020718A1/es not_active Application Discontinuation
- 2001-12-17 KR KR1020037007778A patent/KR100883461B1/ko not_active Expired - Fee Related
- 2001-12-17 ES ES01991315T patent/ES2230385T3/es not_active Expired - Lifetime
- 2001-12-17 SK SK770-2003A patent/SK286703B6/sk not_active IP Right Cessation
- 2001-12-17 CA CA002432798A patent/CA2432798C/en not_active Expired - Fee Related
- 2001-12-17 DK DK01991315T patent/DK1347987T3/da active
- 2001-12-17 TR TR2004/02758T patent/TR200402758T4/xx unknown
- 2001-12-17 SI SI200130228T patent/SI1347987T1/xx unknown
- 2001-12-17 BR BR0116212-8A patent/BR0116212A/pt active Search and Examination
- 2001-12-18 TW TW090131349A patent/TWI316942B/zh not_active IP Right Cessation
- 2001-12-19 MY MYPI20015742A patent/MY129148A/en unknown
2003
- 2003-05-13 ZA ZA200303694A patent/ZA200303694B/en unknown
- 2003-06-19 NO NO20032806A patent/NO326981B1/no not_active IP Right Cessation
- 2003-06-19 MA MA27205A patent/MA26975A1/fr unknown
- 2003-06-19 EC EC2003004659A patent/ECSP034659A/es unknown
2004
- 2004-11-19 GE GEAP8505A patent/GEP20053548B/en unknown
2007
- 2007-10-08 CY CY20071101279T patent/CY1106912T1/el unknown
2008
- 2008-08-29 NO NO20083737A patent/NO20083737L/no not_active Application Discontinuation
2009
- 2009-03-25 JP JP2009075266A patent/JP2009132745A/ja active Pending

Also Published As

Publication number	Publication date
KR100883461B1 (ko)	2009-02-16
MY129148A (en)	2007-03-30
RU2297422C2 (ru)	2007-04-20
PL208242B1 (pl)	2011-04-29
JP2009132745A (ja)	2009-06-18
CA2432798C (en)	2007-02-27
DK1347987T3 (da)	2005-01-31
DE60106489D1 (de)	2004-11-18
IL155771A0 (en)	2003-12-23
NO20032806L (no)	2003-08-19
AU3104902A (en)	2002-07-01
PL363237A1 (en)	2004-11-15
PE20020718A1 (es)	2002-08-09
GEP20053548B (en)	2005-06-27
EP1347987A1 (de)	2003-10-01
US20020137690A1 (en)	2002-09-26
DE60129863T2 (de)	2008-04-30
ES2230385T3 (es)	2005-05-01
MXPA03005671A (es)	2003-10-06
DE60106489T2 (de)	2005-10-13
CZ20031674A3 (cs)	2003-10-15
DK1593670T3 (da)	2007-11-05
JP4351842B2 (ja)	2009-10-28
AU2002231049B2 (en)	2006-07-20
AR035611A1 (es)	2004-06-16
CA2432798A1 (en)	2002-06-27
WO2002050090A8 (en)	2004-04-15
JP2004516299A (ja)	2004-06-03
ES2287826T3 (es)	2007-12-16
PT1347987E (pt)	2005-01-31
HK1056735A1 (en)	2004-02-27
ATE279425T1 (de)	2004-10-15
HUP0302269A2 (hu)	2003-10-28
NZ525722A (en)	2004-11-26
CN100475829C (zh)	2009-04-08
NO20083737L (no)	2003-08-19
KR20030063414A (ko)	2003-07-28
HK1084945A1 (en)	2006-08-11
EP1347987B1 (de)	2004-10-13
BR0116212A (pt)	2003-12-30
NO20032806D0 (no)	2003-06-19
SI1593670T1 (sl)	2007-12-31
TWI316942B (en)	2009-11-11
ATE369334T1 (de)	2007-08-15
SK286703B6 (sk)	2009-03-05
SI1347987T1 (en)	2005-02-28
TR200402758T4 (tr)	2004-11-22
MA26975A1 (fr)	2004-12-20
CY1106912T1 (el)	2012-09-26
CN1483039A (zh)	2004-03-17
CZ302193B6 (cs)	2010-12-08
RU2003122520A (ru)	2005-02-27
PT1593670E (pt)	2007-11-08
WO2002050090A1 (en)	2002-06-27
SK7702003A3 (en)	2003-10-07
ZA200303694B (en)	2004-08-13
NO326981B1 (no)	2009-03-30
HUP0302269A3 (en)	2009-08-28
ECSP034659A (es)	2003-07-25

Publication	Publication Date	Title
DE60129863D1 (de)	2007-09-20	Hydroxysubstituierte 2-Azetidinone verwendbar als Hypocholesterolemische Arzneimittel
AU2002231049A1 (en)	2002-09-05	Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
FI961300A7 (fi)	1996-03-21	Hydroksisubstituoituja atsetidinoniyhdisteitä, jotka ovat käyttökelpoisia hypokolesterolemisia yhdisteitä
ATE219495T1 (de)	2002-07-15	Zuckersubstituierte 2-azetidinone, verwendbar als hypocholesterdenische arzneimittel
HUP0303526A3 (en)	2004-11-29	Enantioselective synthesis of azetidinone intermediate compounds
NO20032194D0 (no)	2003-05-15	Vibrasjonssikt
ATE396720T1 (de)	2008-06-15	Glukokinase beeinflussende verbindungen
DK1226422T3 (da)	2008-04-14	Overflade-forstærkede spektroskopi-aktive nano-partikler
DE60112064D1 (de)	2005-08-25	Benzoamid-piperidin verbindungen als substanz p-antagonisten
NO20030018L (no)	2003-01-30	Vibrasjonssikt
FR2843800B3 (fr)	2004-07-02	Plaque de reference de fluorescence
DE502004009059D1 (de)	2009-04-09	11-((4R,6R)-4,5,6-Trihydroxy-3-(R)-hydroxy-2-(S)-hydroxy-hexylcarbamoyl)-Undekansäure
EP1447978A4 (de)	2005-11-16	Videosynthesizer
HUP0402586A3 (en)	2011-05-30	Pharmaceutical compositions based on azetidine derivatives
DE50206096D1 (de)	2006-05-11	Substituierte benzoäbüazepin-2-on-verbindungen als schmerzmittel
ES1050610Y (es)	2002-08-16	Tornillo de seguridad.
ATE309239T1 (de)	2005-11-15	Aminopyrrol verbindungen als entzündungshemmende wirkstoffe
AU2002366536A1 (en)	2003-06-23	Pillar formwork
DE60205752D1 (de)	2005-09-29	Rückprojektionsschirm
AT500080B1 (de)	2006-04-15	Trichterschirm
NO20025598D0 (no)	2002-11-21	Svingdör
EP1289913A4 (de)	2005-12-21	Neue antibiotische verbindungen
PL340313A1 (en)	2000-11-20	Self-supporting gate
FI20000935A0 (fi)	2000-04-19	Ruuvirakenne
ES1048560Y (es)	2001-12-16	Pantalan de hormigon

Legal Events

Date	Code	Title	Description
2008-08-28	8364	No opposition during term of opposition